|
801 Society
petitions Privy Council for new Charter but the controversy continues The
Council of the Royal Pharmaceutical Society petitioned the Privy Council
last week for a new Royal Charter. However, controversy continues to
reign with five Council members and the Save Our Society campaign issuing
statements expressing disappointment with aspects of the final draft
Charter and the process by which it was produced ...more
801 NICE
looking to double guidance produced in 2004 The National Institute
for Clinical Excellence is to double the amount of guidance it produces
next year, its chairman has said ...more
802 Pharmacists
put at the centre of plans to increase patient choice in the NHS Pharmacists
will play a key role in the Department of Health's plans to expand patient
choice within the National Health Service in England ...more
802 Two
of six NHS electronic records contracts awarded National telecommunications provider BT has been awarded a 10-year, £620m contract to set up and run the National Health Service Care Records Service for England
...more
803 Antidepressant
warning extended to other SSRIs A government warning not to
use paroxetine or venlafaxine (Efexor) to treat depression in children
has been extended to include sertraline (Lustral), citalopram (Cipramil),
escitalopram (Cipralex) and fluvoxamine. The only selective serotonin
reuptake inhibitor not to be included in the warning is fluoxetine ...more
803 CSM
adviser stands down over latest HRT warnings An adviser to
the Committee on Safety of Medicines has stood down from his position
on an expert working group following the committee's latest recommendations
on hormone replacement therapy (HRT) ...more
803 Improving
prescribing practice needs culture change The benefits of
pharmacist and nurse prescribing will be limited unless changes are made
to the structure and culture of the health service, according to Professor
Sir Michael Rawlins, chairman of the National Institute for Clinical
Excellence ...more
803 GPs
cannot use adrenaline devices Most patients with a diagnosis
of anaphylaxis do not know how and when to use auto-injecting adrenaline,
and neither do their general practitioners ...more
803 Herbal
creams contain steroids Many herbal creams reported as being
effective for the treatment of childhood eczema contain corticosteroids,
a new study indicates ...more
804 Pharmacists could have greater input in managing patients with dyspepsia Pharmacists
could become more involved in the management of patients with dyspepsia
when new National Institute for Clinical Excellence guidelines are released,
according to Dr Richard Stevens, chairman of the Primary Care Society
for Gastroenterology ...more
804 Wales
explores central purchasing Central purchasing of medicines
for use in primary care in Wales is to be investigated to see whether
a workable system can be developed ...more
804 MeReC looks at angiotensin drugs Evidence
to support the combined use of an angiotensin converting enzyme inhibitor
and an angiotensin II receptor antagonist in hypertension, renal disease
and heart failure is, as yet, unconvincing ...more
804 Co-ordinate
diabetes services Pharmacy diabetes services in Wales should
be better quality controlled, according to the Audit Commission's recent
review into diabetes services in Wales ...more
804 Equal
benefit for antihypertensives Patients with coronary artery
disease who need treatment for high blood pressure gain similar benefits
whether their treatment regimen is based on a calcium channel blocker
or on a beta blocker, study data indicate ...more
805 Refit
boosts business for UniChem award winner A total refit of
Medicine Box Chemist, Leicester, and the provision of an extended range
of services has led to Unnat Patel being named overall winner of the
UniChem Great Business awards for 2003 ...more
805 AAH
and East Anglian call off merger deal AAH Pharmaceuticals
and East Anglian Pharmaceuticals have cancelled their proposed merger
...more
805 Derby
awards its first DPharm degree Mojgan Sani has been awarded
a doctor of practice in pharmacy (DPharm) degree by the University of
Derby, the first time such a degree has been awarded in the United Kingdom
...more
805 Two developments
widen availability of oseltamivir for 'flu Two moves have
been made to make oseltamivir (Tamiflu) more available for the treatment
and prophylaxis of influenza ...more
|
Research & Development
AHA conference
Reports
806 Ximelagatran
is effective alternative to warfarin A new oral anti-clotting
drug, ximelagatran (Exanta), is an effective alternative to warfarin
for preventing stroke in patients with atrial fibrillation, researchers
say ...more
806 New agent
provides novel approach for heart failure therapy Tolvaptan,
an oral vasopressin-2 antagonist, may provide a new approach to treating
heart failure ...more
806 Pexelizumab
for heart surgery Pexelizumab, an antibody fragment that inhibits
complement activity, might be useful in coronary artery bypass graft
(CABG) surgery, research shows ...more
806 Use of cariporide
post-surgery Cariporide, a sodium/hydrogen exchange inhibitor,
might reduce the risk of myocardial infarction in patients undergoing
coronary artery bypass graft surgery ...more
Other R & D news
806 New anaemia
drug shows promise A new anaemia drug, CERA (continuous erythropoiesis
receptor activator), shows sustained stimulation of red blood cell formation
when given once every three weeks, to kidney dialysis patients with chronic
renal anaemia ...more
806 New anxiolytics
from quinolones? Patients taking fluoroquinolone antibiotics
exhibit a low incidence of convulsions and anxiety, probably via GABA
antagonism at the brain GABA receptor complex ...more
807 GSK R&D pipeline has 147 projects GlaxoSmithKline
unveiled compounds in its research and development pipeline to investors
last week, revealing 147 projects, including 82 new chemical entities
...more
807 Italian gene
discovery leads to atherosclerosis treatment trial The identification
of a genetic mutation in some Italian villagers has led to the first
clinical trial of an agent to reduce atherosclerosis in acute coronary
syndromes ...more
807 New psoriasis
treatment expected Efalizumab, a humanised therapeutic antibody,
has shown promise as a treatment for moderate to severe psoriasis ...more
807 Painfree
microneedles Researchers have developed microneedles, measuring
from 1 to 1,000 microns, small enough to avoid significantly stimulating
nerve endings when penetrating the skin ...more
807 New prostate
agents A potential new agent for benign prostatic hyperplasia
has been developed by a team at University College London ...more
807 Ebola vaccine
hope Researchers have successfully immunised mice against
the deadly Ebola virus in the hope of developing a human vaccine ...more
|
